Dr Jekyll and Ms Hide

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Liver polyploidy: Dr Jekyll or Mr Hide?

Polyploidization is a state in which cells possess more than two sets of homologous chromosomes, which occurs frequently in nature [1]. In Mammals, whole organism polyploidy is usually lethal; however, some tissues develop a certain degree of polyploidy during their normal lifecycle. Polyploid cells are generated because of cell fusion or abnormal cell division (e.g. endoreplication, mitotic sl...

متن کامل

Uric Acid for Cardiovascular Risk: Dr. Jekyll or Mr. Hide?

Uric acid (UA) is a potent endogenous antioxidant. However, high concentrations of this molecule have been associated with cardiovascular disease (CVD) and renal dysfunction, involving mechanisms that include oxidative stress, inflammatory processes, and endothelial injury. Experimental and in vitro results suggest that this biomarker behaves like other antioxidants, which can shift from the ph...

متن کامل

Jekyll and Hide

Neurodegenerative diseases are a burden of our century. Although significant efforts were made to find a cure or relief to this scourge, their pathophysiology remains vague and the cellular function of the key involved proteins is still unclear. However, in the case of amyloid β (Aβ), a key protein concerned in Alzheimer disease, we are now a step closer in the unscrambling of its cellular func...

متن کامل

Dr Jekyll and Mr C

Jekyll is a high level programming language that can be translated losslessly to and from human readable, human editable C. This makes it possible to maintain Jekyll and C versions of the same file, with any changes made to one file being automatically reflected into the other. By being losslessly inter-translatable with C, Jekyll reduces the switching costs normally associated with moving to a...

متن کامل

Tamoxifen: Dr. Jekyll and Mr. Hyde?

Without regard to patient selection, other than the eligibility requirements for entry into the studies, worldwide overviews of prospective clinical trials demonstrate that adjuvant tamoxifen reduces the annual odds of death for women with invasive breast cancer by approximately 15% over 10–15 years (1). These data raise the provocative question: Should all patients with invasive breast cancer ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Nature

سال: 2007

ISSN: 0028-0836,1476-4687

DOI: 10.1038/nj7140-114a